Reactions 1680, p144 - 2 Dec 2017 Peripheral sensory neuropathy: case report In a retrospective study of 143 patients , a patient [age and sex not stated] was described who developed grade 3 peripheral sensory neuropathy after receiving oxaliplatin, folinic acid [leucovorin], fluorouracil [5-fluorouracil]. The patient, who had stage 3 colon cancer, received FOLFOX4 regimen which included oxaliplatin 85 mg/m as two hour infusion on day one, folinic acid [dose not clearly stated] as two hour infusion on day one and day two, and an IV bolus of fluorouracil 400 mg/m as loading dose, followed by fluorouracil 600 mg/m via ambulatory pump for 22 hours on day one and day two. All doses were given biweekly. The patient developed grade 3 peripheral sensory neuropathy [duration of treatment to reaction onset and outcome not stated]. Author comment: "15 FOLFOXU patients (18.5%) experienced peripheral sensory neuropathy (grade 3 in 1 FOLFOX4 patient and in 2 FOLFOXU patients)". Huang M-Y, et al. Comparison of adjuvant FOLFOX4 chemotherapy and oral UFUR/LV following adjuvant FOLFOX4 chemotherapy in patients with stage III colon cancer subsequent to radical resection. Oncology Letters 14: 6754-6762, No. 6, Dec 2017. Available from: URL: http://doi.org/10.3892/ol.2017.7073 - Taiwan 803284405 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera